Facebook
Twitter
LinkedIn
ForwardReshaping Allergy Practice with Emerging Health and Communication Technology Tools (MOC)
This course if part of the 2017 Virtual Annual Meeting. Want more virtual meeting recordings? Save by ordering the full set!
Session 1804 from the 2017 AAAAI Annual Meeting addresses patient and medication tracking and tasks that are central to the practicing allergist-immunologist. Several healthcare initiatives, including quality-of-care measurement, pay-for-performance, population-based health management and press the importance of tracking patients and medications. This session will feature recent engineering, health information technology, and social and behavioral science advances that provide new capabilities for registry developments that facilitate improved patients and medication tracking.
- Upon completion of this activity:
The American Board of Allergy and Immunology (ABAI) has approved this activity for 1.25 MOC Part II Self-Assessment credits. These credits will be awarded once you have completed all components of the course.
Target Audience
Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss how to construct disease registries to track medication usage in allergy practices
- Describe communication and health technology tools with potential to reshape allergy practice
- Identify strategies to improve adherence to allergy and asthma medications
Faculty
Dr. Bruce G. Bender, PhD FAAAAI
National Jewish Health, Denver, CO
Relevant relationships:
Dr. Linda Cox, MD FAAAAI
Allergy & Asthma Center, Fort Lauderdale, FL
Relevant relationships:
Dr. Giselle Mosnaim, MD MS FAAAAI
Rush University Medical Center, Chicago, IL
Relevant relationships:
Reviewers
Robert Corriel, MD FAAAAI
Manhasset Allergy and Asthma Associates, Manhasset, NY
Relevant relationships: None
Karen Gregory, DNP APRN-BC RRT AE-C
Oklahoma Allergy and Asthma Clinic, Edmond, OK
Relevant relationships: Merck, MEDA and Novartis: speakers bureau
Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 1.25 Contact Hours.
Medium and Method of Physician Participation for an Enduring Activity
Follow these steps to complete the activity:
- Register for the activity.
- Review the CME and Disclosure information.
- Complete all required components.
- Complete the post-test. You must achieve a score of 70% or higher on post-tests to claim credit.
- Complete the activity evaluation.
- Claim your credits. Enter only the number of credits earned based on your participation in the activity.
- Print or save your certificate.
AAAAI Privacy Policy
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.
Release date
Original release date: June 1, 2017. Valid for credit through May 31, 2019.
Questions
Activity-related questions should be directed to cme@aaaai.org
Available Credit
- 1.25 AttendanceAttendance credit.
- 1.25 CECE credit.
- 1.25 CMECME credit.